KindlyMD, Inc. (NASDAQ:NAKA) Given Average Rating of "Hold" by Analysts

Key Points

• KindlyMD has a consensus analyst rating of "Hold" from five covering firms, with an average 12-month price target of $30.00. The breakdown includes one sell, one hold, and three buy ratings.
• The stock recently traded at $4.06, up 2.3% on the day, but remains far below its 52-week high of $659.20. The company also reported weak recent fundamentals, including a quarterly EPS loss of ($0.38) on revenue of $2.68 million.
• Insider and institutional activity has been notable, including CEO David F. Bailey buying 104,833 shares in late May. Insiders have purchased a total of 191,448 shares over the last 90 days, while several hedge funds and institutions have also added positions.

KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) has been assigned a consensus rating of "Hold" from the five research firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $30.00.

A number of research firms recently commented on NAKA. Weiss Ratings upgraded shares of KindlyMD from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Monday, May 11th. TD Cowen began coverage on KindlyMD in a research note on Friday, April 10th. They set a "buy" rating and a $40.00 price target for the company. Maxim Group lowered their price target on KindlyMD from $60.00 to $30.00 and set a "buy" rating on the stock in a research report on Monday, April 6th. Finally, Wall Street Zen upgraded KindlyMD to a "sell" rating in a research report on Saturday, May 23rd.

KindlyMD Stock Up 2.3%

Shares of NAKA opened at $4.06 on Friday. The firm has a 50-day moving average price of $4.92 and a 200 day moving average price of $9.29. The firm has a market capitalization of $70.64 million, a PE ratio of -0.09 and a beta of 16.05. KindlyMD has a 52-week low of $3.33 and a 52-week high of $659.20.

KindlyMD (NASDAQ:NAKA - Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.38) EPS for the quarter. The company had revenue of $2.68 million for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%. On average, equities analysts expect that KindlyMD will post -16.8 EPS for the current year.

Insiders Place Their Bets

In other news, CEO David F. Bailey bought 104,833 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were purchased at an average cost of $4.84 per share, with a total value of $507,391.72. Following the completion of the acquisition, the chief executive officer directly owned 3,120,361 shares in the company, valued at approximately $15,102,547.24. The trade was a 3.48% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders bought a total of 191,448 shares of company stock worth $992,908 over the last ninety days. Company insiders own 24.49% of the company's stock.

Institutional Investors Weigh In On KindlyMD

Institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in shares of KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company's stock worth $484,000 after purchasing an additional 8,386 shares during the last quarter. Osaic Holdings Inc. bought a new stake in shares of KindlyMD in the 2nd quarter worth approximately $215,000. Victory Capital Management Inc. acquired a new stake in KindlyMD during the third quarter valued at approximately $1,007,000. UBS Group AG lifted its stake in KindlyMD by 5,244.3% during the third quarter. UBS Group AG now owns 387,142 shares of the company's stock valued at $9,655,000 after purchasing an additional 379,898 shares during the last quarter. Finally, Quadrature Capital Ltd bought a new stake in KindlyMD during the third quarter worth approximately $5,460,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.